CVS considers breaking up the company as investors urge turnaround — reports

Struggling healthcare giant CVS Health is considering breaking up the company, including separating its pharmacy and insurance businesses, as part of a strategic review, …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial

Exscientia has backed the CDK7 candidate as the company “believes GTAEXS617 has the potential to overcome significant safety and efficacy limitations of existing approved treatments”.

July 19, 2024

Azenta in robotics: Theme innovation strategy

Share this article Azenta grant share with robotics as a theme is 70% in Q4 2023. Grant share is based on the ratio of number

March 5, 2024

Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test

What You Should Know: – Karius®, a leader in genomic diagnostics for infectious disease, announced today the closing of a $100 million Series C funding

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.